Effect of chemotherapy and radiotherapy on cognitive impairment in colorectal cancer: evidence from a nationally representative longitudinal database of Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: We investigated the risk of chemotherapy-related and radiotherapy-related cognitive impairment in colorectal cancer patients. METHODS: Medical use data of colorectal cancer patients were obtained from the Korean National Health Insurance Database from 2004 to 2018. We randomly selected 40% of all colorectal cancer patients (n= 148,848). Cognitive impairment was defined as having 1 or more International Classification of Diseases, 10th revision diagnostic codes for dementia or mild cognitive impairment. Patients aged 18 years or younger, patients diagnosed with cognitive impairment before colorectal cancer diagnosis (n= 8,225), and patients who did not receive primary resection (n= 45,320) were excluded. The effects of individual chemotherapy regimens on cognitive impairment were estimated. We additionally estimated the effect of radiotherapy in rectal cancer patients. Time-dependent competing risk Cox regression was conducted to estimate the overall and age-specific hazard ratios (HR) separately for colon and rectal cancer. Landmark analyses with different lag times were conducted as sensitivity analyses. RESULTS: Chemotherapy did not increase the risk of cognitive impairment in colorectal cancer patients (colon cancer: HR, 0.92; 95% confidence interval [CI], 0.83 to 1.03; rectal cancer: HR, 0.88; 95% CI, 0.75 to 1.04), while radiotherapy was negatively associated with cognitive impairment in rectal cancer patients (HR, 0.01; 95% CI, 0.84 to 0.99). Varying directions of the associations between regimens and cognitive impairment were detected. The adverse effect of certain chemotherapy regimens on cognition was more prominent in older adults. CONCLUSIONS: Chemotherapy and radiotherapy did not increase the risk of cognitive impairment. Older patients with low cognitive reserve could be affected by the adverse cognitive effects of chemotherapy.
Abstract
OBJECTIVES: We investigated the risk of chemotherapy-related and radiotherapy-related cognitive impairment in colorectal cancer patients. METHODS: Medical use data of colorectal cancer patients were obtained from the Korean National Health Insurance Database from 2004 to 2018. We randomly selected 40% of all colorectal cancer patients (n= 148,848). Cognitive impairment was defined as having 1 or more International Classification of Diseases, 10th revision diagnostic codes for dementia or mild cognitive impairment. Patients aged 18 years or younger, patients diagnosed with cognitive impairment before colorectal cancer diagnosis (n= 8,225), and patients who did not receive primary resection (n= 45,320) were excluded. The effects of individual chemotherapy regimens on cognitive impairment were estimated. We additionally estimated the effect of radiotherapy in rectal cancer patients. Time-dependent competing risk Cox regression was conducted to estimate the overall and age-specific hazard ratios (HR) separately for colon and rectal cancer. Landmark analyses with different lag times were conducted as sensitivity analyses. RESULTS: Chemotherapy did not increase the risk of cognitive impairment in colorectal cancer patients (colon cancer: HR, 0.92; 95% confidence interval [CI], 0.83 to 1.03; rectal cancer: HR, 0.88; 95% CI, 0.75 to 1.04), while radiotherapy was negatively associated with cognitive impairment in rectal cancer patients (HR, 0.01; 95% CI, 0.84 to 0.99). Varying directions of the associations between regimens and cognitive impairment were detected. The adverse effect of certain chemotherapy regimens on cognition was more prominent in older adults. CONCLUSIONS: Chemotherapy and radiotherapy did not increase the risk of cognitive impairment. Older patients with low cognitive reserve could be affected by the adverse cognitive effects of chemotherapy.
참고문헌 (40)
- Bernstein LJ, "Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed : a multilevel meta-analysis", Neurosci Biobehav Rev, 83, pp.417~428 (2017)
- Matsuda T, "Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms", Breast Cancer, 12, pp.279~287 (2005)
- Dietrich J, "Chemotherapy, cognitive impairment and hippocampal toxicity", Neuroscience, 309, pp.224~232 (2015)
- Cruzado JA, "Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients", Support Care Cancer, 22, pp.1815~1823 (2014)
- Vardy JL, "Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy : a prospective, longitudinal, controlled study", J Clin Oncol, 33, pp.4085~4092 (2015)
- Bruheim K, "Late side effects and quality of life after radiotherapy for rectal cancer", Int J Radiat Oncol Biol Phys, 76, pp.1005~1011 (2010)
- Couwenberg AM, "Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis", Clin Colorectal Cancer, 17, pp.e499~e512 (2018)
- Allal AS, "Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy : a longitudinal prospective study", Int J Radiat Oncol Biol Phys, 61, pp.1129~1135 (2005)
- Ahles TA, "Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer : impact of age and cognitive reserve", J Clin Oncol, 28, pp.4434~4440 (2010)
- Whalley LJ, "Cognitive reserve and the neurobiology of cognitive aging", Ageing Res Rev, 3, pp.369~382 (2004)
- Hurria A, "Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer : a pilot prospective longitudinal study", J Am Geriatr Soc, 54, pp.925~931 (2006)
- 황수영, "Neurocognitive Effects of Chemotherapy for Colorectal Cancer: A Systematic Review and a Meta-Analysis of 11 Studies", Cancer Research and Treatment, 53(4), pp.1134~1147 (2021), 대한암학회[DOI]
- Kwon S, "Thirty years of national health insurance in South Korea : lessons for achieving universal health care coverage", Health Policy Plan, 24, pp.63~71 (2009)
- Seong SC, "Data resource profile : the National Health Information Database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
- Shin J, "Inhaled corticosteroids in COPD and the risk for coronary heart disease : a nationwide cohort study", Sci Rep, 10, pp.18973~ (2020)
- Suh Y, "Dose response relationship of cumulative anticholinergic exposure with incident dementia : validation study of Korean anticholinergic burden scale", BMC Geriatr, 20, pp.265~ (2020)
- Lee J, "Use of sedative-hypnotics and the risk of Alzheimer’s dementia : a retrospective cohort study", PLoS One, 13, pp.e0204413~ (2018)
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- Benson AB, "NCCN guidelines insights : colon cancer, version 2. 2018", J Natl Compr Canc Netw, 16, pp.359~369 (2018)
- Benson AB, "Rectal cancer, version 2. 2018, NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 16, pp.874~901 (2018)
- Latouche A, "A note on including time-dependent covariate in regression model for competing risks data", Biom J, 47, pp.807~814 (2005)
- Ning J, "Estimation of time-dependent association for bivariate failure times in the presence of a competing risk", Biometrics, 70, pp.10~20 (2014)
- Fuerst D, "Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects", Haematologica, 103, pp.1527~1534 (2018)
- Ng DK, "Nonparametric assessment of differences between competing risk hazard ratios : application to racial differences in pediatric chronic kidney disease progression", Clin Epidemiol, 12, pp.83~93 (2020)
- Lévesque LE, "Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes", BMJ, 340, pp.b5087~ (2010)
- Suissa S, "Immortal time bias in observational studies of drug effects", Pharmacoepidemiol Drug Saf, 16, pp.241~249 (2007)
- Austin PC, "A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model", Stat Med, 39, pp.103~113 (2020)
- Leona S, "Multiple regression: testing and interpreting interactions", pp.31~60 (1996), SAGE
- Anderson JR, "Analysis of survival by tumor response", J Clin Oncol, 1, pp.710~719 (1983)
- Bower JE, "Behavioral symptoms in patients with breast cancer and survivors", J Clin Oncol, 26, pp.768~777 (2008)
- Pilevarzadeh M, "Global prevalence of depression among breast cancer patients : a systematic review and metaanalysis", Breast Cancer Res Treat, 176, pp.519~533 (2019)
- Peng YN, "Prevalence of depression and anxiety in colorectal cancer patients : a literature review", Int J Environ Res Public Health, 16, pp.411~ (2019)
- Lange M, "Cancer-related cognitive impairment : an update on state of the art, detection, and management strategies in cancer survivors", Ann Oncol, 30, pp.1925~1940 (2019)
- Vardy J, "Cognitive function and fatigue after diagnosis of colorectal cancer", Ann Oncol, 25, pp.2404~2412 (2014)
- Ahles TA, "Brain vulnerability to chemotherapy toxicities", Psychooncology, 21, pp.1141~1148 (2012)
- Maccormick RE, "Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty?", Med Hypotheses, 67, pp.212~215 (2006)
- Ahles TA, "Cancer-and cancer treatment-associated cognitive change : an update on the state of the science", J Clin Oncol, 30, pp.3675~3686 (2012)
- Janelsins MC, "Prevalence, mechanisms, and management of cancer-related cognitive impairment", Int Rev Psychiatry, 26, pp.102~113 (2014)
- Kang J, "Risk of dementia in prostate cancer survivors : a nationwide cohort study in Korea", Curr Probl Cancer, 44, pp.100578~ (2020)
- Kleinbaum DG, "Survival analysis", pp.426~451 (2010), Springer